Former GSK Exec Steven Skolsky Becomes Trimeris CEO
This article was originally published in The Pink Sheet Daily
Executive Summary
Skolsky succeeds company founder Dani Bolognesi, who will stay on as chief scientific officer. Previously, Skolsky was GlaxoSmithKline senior VP-global commercial strategy.